The Fellow on Call: The Heme/Onc Podcast cover image

Episode 048: Myeloma Series, Pt.9- Transplant in Myeloma Capstone

The Fellow on Call: The Heme/Onc Podcast

00:00

Would You Consider a Second Transplant?

The utility of a second transplant is not something that's been born out in sequential studies. Unless a patient has achieved a rate amount out of their first transplant, and what I mean by that is several years past the average, right? So we expect at least four to five years of control disease or progression-free survival with upfront transplant. If they have not achieved that, their likelihood of achieving anything close to that is very slim with the second transplant.

Play episode from 45:11
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app